ÂÜÀòÂÒÂ×

The Research and Development Team at Tubulis is responsible for innovating and developing uniquely matched protein-drug conjugates (ADCs) by leveraging proprietary technologies and disease-specific biology. Comprised of experts in chemistry, bioconjugation, cell biology, and analytical development, the team works collaboratively to enhance the therapeutic potential of ADCs, navigate developmental challenges, and drive both in-house discovery and partnerships with other entities possessing antibody and chemical assets. Their ultimate goal is to create advanced conjugates that improve patient outcomes across a diverse range of medical indications.